ATE175204T1 - Orthomolekulares verfahren zur behandlung von sichelzellanämie - Google Patents

Orthomolekulares verfahren zur behandlung von sichelzellanämie

Info

Publication number
ATE175204T1
ATE175204T1 AT92904928T AT92904928T ATE175204T1 AT E175204 T1 ATE175204 T1 AT E175204T1 AT 92904928 T AT92904928 T AT 92904928T AT 92904928 T AT92904928 T AT 92904928T AT E175204 T1 ATE175204 T1 AT E175204T1
Authority
AT
Austria
Prior art keywords
orthomolecular
sickle cell
cell anemia
treating sickle
treating
Prior art date
Application number
AT92904928T
Other languages
English (en)
Inventor
Michael Wilburn
Original Assignee
Michael Wilburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Wilburn filed Critical Michael Wilburn
Application granted granted Critical
Publication of ATE175204T1 publication Critical patent/ATE175204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92904928T 1991-02-08 1992-01-31 Orthomolekulares verfahren zur behandlung von sichelzellanämie ATE175204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/652,773 US5108754A (en) 1991-02-08 1991-02-08 Orthomolecular method of treating sickle cell disease

Publications (1)

Publication Number Publication Date
ATE175204T1 true ATE175204T1 (de) 1999-01-15

Family

ID=24618098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904928T ATE175204T1 (de) 1991-02-08 1992-01-31 Orthomolekulares verfahren zur behandlung von sichelzellanämie

Country Status (15)

Country Link
US (1) US5108754A (de)
EP (1) EP0571474B1 (de)
JP (1) JPH06507382A (de)
KR (1) KR100221118B1 (de)
AP (1) AP275A (de)
AT (1) ATE175204T1 (de)
AU (1) AU662124B2 (de)
BR (1) BR9205609A (de)
CA (1) CA2103580C (de)
DE (1) DE69228054T2 (de)
DK (1) DK0571474T3 (de)
ES (1) ES2125887T3 (de)
GR (1) GR3029742T3 (de)
IL (1) IL100663A (de)
WO (1) WO1992013522A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
HUT72422A (en) * 1994-04-20 1996-04-29 Beres Export Import Rt Aquous concentrate and process for its preparation
US5626884A (en) * 1995-08-18 1997-05-06 Lockett; Curtis G. Treatment of sickle cell disease
US5693671A (en) * 1996-05-01 1997-12-02 Harbor-Ucla Research And Education Institute L-glutamine therapy for sickle cell diseases and thalassemia
US20080153761A1 (en) * 1998-04-08 2008-06-26 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
KR20020088498A (ko) * 2001-05-17 2002-11-29 (주)미토콘 에스-아데노실메티오닌을 유효성분으로 함유하는 인슐린저항증 개선용 조성물
DE10243234A1 (de) * 2002-09-17 2004-03-25 Phenion Gmbh & Co. Kg Tocopherylester
WO2005007173A1 (en) * 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
EP2237788A4 (de) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc Aerosolisierte nitrit- und stickoxidspendende verbindungen und ihre verwendung
US8840950B2 (en) 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
CN107075441A (zh) * 2014-07-30 2017-08-18 卡斯西部储备大学 诊断血红蛋白病症和监测血细胞的生物芯片
EP3204004A4 (de) * 2014-10-08 2018-05-30 Epigenetics Pharma LLC Vitamin-e-nukleosidprodrugs
WO2016196281A1 (en) * 2015-06-01 2016-12-08 Nanometics Llc Mtap inhibitors for the treatment of sickle cemtap disease
US10349589B2 (en) 2016-09-08 2019-07-16 Hemex Health, Inc. Diagnostics systems and methods
EP3510396B1 (de) 2016-09-08 2021-12-08 Hemex Health, Inc. Diagnosesystem
KR20190092778A (ko) 2018-01-31 2019-08-08 양원용 태양광을 이용한 기능성 전동식 농약분무기
US11740203B2 (en) 2019-06-25 2023-08-29 Hemex Health, Inc. Diagnostics systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57609A (en) * 1979-06-21 1983-05-15 Yeda Res & Dev Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease

Also Published As

Publication number Publication date
AU1250592A (en) 1992-09-07
CA2103580C (en) 2002-11-26
AP9200358A0 (en) 1992-04-30
JPH06507382A (ja) 1994-08-25
US5108754A (en) 1992-04-28
AP275A (en) 1993-07-18
EP0571474A1 (de) 1993-12-01
AU662124B2 (en) 1995-08-24
KR100221118B1 (ko) 1999-09-15
ES2125887T3 (es) 1999-03-16
CA2103580A1 (en) 1992-08-09
EP0571474A4 (de) 1994-02-09
IL100663A0 (en) 1992-09-06
IL100663A (en) 1995-10-31
WO1992013522A1 (en) 1992-08-20
EP0571474B1 (de) 1998-12-30
BR9205609A (pt) 1994-07-26
DK0571474T3 (da) 1999-08-30
DE69228054D1 (de) 1999-02-11
DE69228054T2 (de) 1999-08-05
GR3029742T3 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
ATE175204T1 (de) Orthomolekulares verfahren zur behandlung von sichelzellanämie
DE69218202D1 (de) Verfahren zur behandlung von fluoroaluminosilikatgläsern
DE69231386D1 (de) Verfahren zur behandlung von blattgemüse zur verlängerung der lagerungszeit
DE69331469D1 (de) Verfahren zur behandlung von abfällen
DE3380895D1 (de) Verfahren zur behandlung von eiern.
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
DE3152893A1 (de) Verfahren und zusammensetzung zur behandlung von akne
DE69417018D1 (de) Verfahren zur behandlung von teilchenmaterial
ATA237789A (de) Verfahren zur behandlung von nassem nadel- oder laubbaumholz
AT380769B (de) Verfahren zur behandlung von zu verkaufendem gemuese
DE3668172D1 (de) Verfahren zur behandlung von aktiviertem siliciumpulver.
DE3861527D1 (de) Verfahren zur behandlung von photolacken.
DE3482141D1 (de) Verfahren zur unterschiedlichen behandlung von winkeldaten.
DE3670145D1 (de) Verfahren zur behandlung von abfall.
DE69114854D1 (de) Verfahren zur behandlung von photographischen abwässern.
DE3584538D1 (de) Verfahren zur behandlung von textilien.
DE58902128D1 (de) Verfahren zur behandlung von klaerschlamm.
ATA307683A (de) Verfahren zur behandlung von warmbluetigen tieren
DE3578161D1 (de) Verfahren zur behandlung von fluessigkeiten.
DE59308384D1 (de) Verfahren zur Behandlung von Gülle
DE69232662D1 (de) Verfahren zur wirkungsverstärkung von mitteln der ersten wahl bei der behandlung mehrfachresistenter zellen
ATA412581A (de) Verfahren zur behandlung von abwasser
DE69112391D1 (de) Verfahren zur reinigung von fluorwasserstoff.
DE3886755D1 (de) Verfahren zur behandlung von gefässkrankheiten.
DE69006509D1 (de) Verfahren zur behandlung von häuten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee